Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 9, 2021
Patent Application Number
15880726
Date Filed
January 26, 2018
Patent Primary Examiner
Patent abstract
The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
